loader from loading.io

“It’s incredibly exciting” - What’s next for Tidepool with CEO Brandon Arbiter

Diabetes Connections | Type 1 Diabetes

Release Date: 02/17/2026

“It’s incredibly exciting” - What’s next  for Tidepool with CEO Brandon Arbiter show art “It’s incredibly exciting” - What’s next for Tidepool with CEO Brandon Arbiter

Diabetes Connections | Type 1 Diabetes

Tidepool was founded in 2013, part of the incredible era of DIY diabetes progress, and has since helped change how hundreds of thousands of people with diabetes see and use their data. I’m talking to CEO Brandon Artibter about how open-source innovation became FDA-cleared technology, and what’s next.. including a new partnership with Oura Ring to study sleep, activity, and menstrual cycles, and continued work with Tidepool Loop. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our previous episodes with...

info_outline
In the News... Trump RX, T1D at the Olympics & Superbowl, Ozempic pill launches soon, and more! show art In the News... Trump RX, T1D at the Olympics & Superbowl, Ozempic pill launches soon, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: ...

info_outline
The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback show art The FDA pulled it, but the diabetes community wouldn’t let it go. How the T1D1 app made a comeback

Diabetes Connections | Type 1 Diabetes

Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but one of them – created by a teenager with type 1 – is back. I’m talking with Drew and Mike Mendelow about a free and ad-free insulin-dose calculator app. They share what it was like to navigate the FDA process, how they go international help, and what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to ...

info_outline
In the News... Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more! show art In the News... Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show is...

info_outline
Chris Dunn got screened for her kids, turns out SHE has type 1 diabetes show art Chris Dunn got screened for her kids, turns out SHE has type 1 diabetes

Diabetes Connections | Type 1 Diabetes

Imagine getting your kids screened for T1D and agreeing to do it yourself, just to set a good example, and then your test is the one that comes back with type 1! That’s exactly what happened to Chris Dunn. She was positive for all of the autoantibodies and has since been treated with Tzield, the medication shown to delay the onset. We’re talking to her about all of that, what the treatment is actually like, how she’s doing since and what her family thinks of the whole thing. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...

info_outline
In the News... New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more! show art In the News... New islets study, Tzield for babies, MiniMed Go approved, Civica insulin launched, and more!

Diabetes Connections | Type 1 Diabetes

It's In the News... the top diabetes stories and headlines happening now! Top stories this week include: new islet encapsulation trial, FDA agrees to review Tzield for babies and approves the MiniMed Go, Civica releases it's version of Lantus, Eversense launches with a pump partner, scholarship for college students with diabetes and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures The best way to keep up...

info_outline
GLP-1s for Type 1 Diabetes: Are We  There Yet? With Dr. Cecilia Low Wang show art GLP-1s for Type 1 Diabetes: Are We There Yet? With Dr. Cecilia Low Wang

Diabetes Connections | Type 1 Diabetes

One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications? We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I’m talking to  Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years,  including serving on FDA advisory committees. This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and...

info_outline
In the News PLUS our 2026 Predictions show art In the News PLUS our 2026 Predictions

Diabetes Connections | Type 1 Diabetes

It's In the News.. a look at the top headlines and stories in the diabetes community. This week we're also making predictions for diabetes news in 2026! This week's top stories: statins and type 2, big results from Lilly's newest weight loss drug, MiniMed IPO, Tandem app update, and more! Predicitons include thouhts around: continuous ketone monitoring, noninvasive gucose moniotring, inhalable insulin for kids, GLP1 backlash, A1 slop in diabetes mom groups and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners -...

info_outline
Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse show art Looking back on 2025: Hype, hope and what really matters, with Neil Greathouse

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections, a conversation about what really matters in diabetes. We’re talking about the top stories of 2025, the hype that didn’t happen, some trends for 2026, what community can accomplish, and what LeBron James has to do with all of this. We also get personal – because I’m being interviewed by the wonderful Neil Greathouse, host of Your Best T1D life, and so much more. This episode contains a replay of This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community...

info_outline
Do We Need an At-Home A1C Test in the  Age of CGM? Orange Biomed Says Yes show art Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes

Diabetes Connections | Type 1 Diabetes

Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...

info_outline
 
More Episodes

Tidepool was founded in 2013, part of the incredible era of DIY diabetes progress, and has since helped change how hundreds of thousands of people with diabetes see and use their data.

I’m talking to CEO Brandon Artibter about how open-source innovation became FDA-cleared technology, and what’s next.. including a new partnership with Oura Ring to study sleep, activity, and menstrual cycles, and continued work with Tidepool Loop.

This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Our previous episodes with Tidepool, including the announcment of bringing Loop to the FDA back in 2018!

https://diabetes-connections.com/?s=tidepool

Announcing Community Commericals! Learn how to get your message on the show here.

Learn more about studies and research at Thrivable here

Please visit our Sponsors & Partners - they help make the show possible!

Omnipod - Simplify Life


All about Dexcom 


All about VIVI Cap to protect your insulin from extreme temperatures

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
Sign up for our newsletter here

Here's where to find us:
Facebook (Group)
Facebook (Page)
Instagram
Check out Stacey's books!

Learn more about everything at our home page www.diabetes-connections.com